FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8070111000001100: Sativex oromucosal spray (GW Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1582371000001113 Sativex oromucosal spray (GW Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1582381000001110 Sativex oromucosal spray (GW Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sativex oromucosal spray (GW Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Is a Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has active ingredient Cannabidiol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has active ingredient Delta-9-tetrahydrocannabinol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has active ingredient Tetrahydrocannabinol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has active ingredient Dronabinol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Is a Sativex true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has specific active ingredient Dronabinol true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has specific active ingredient Cannabidiol true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Is pack of False Sativex oromucosal spray (GW Pharma Ltd) Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 204 dose 4 x 51 doses Is pack of False Sativex oromucosal spray (GW Pharma Ltd) Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has AMP True Sativex oromucosal spray (GW Pharma Ltd) Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 204 dose 4 x 51 doses Has AMP True Sativex oromucosal spray (GW Pharma Ltd) Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 270 dose 3 x 90 doses Has AMP True Sativex oromucosal spray (GW Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start